IRIS
MARAFINI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.588
AS - Asia 3.045
EU - Europa 2.047
Continente sconosciuto - Info sul continente non disponibili 458
SA - Sud America 405
AF - Africa 43
OC - Oceania 4
Totale 21.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.353
SG - Singapore 1.560
IT - Italia 581
CN - Cina 533
BR - Brasile 326
HK - Hong Kong 290
RU - Federazione Russa 281
DE - Germania 201
FI - Finlandia 188
BD - Bangladesh 181
IE - Irlanda 181
VN - Vietnam 165
GB - Regno Unito 128
UA - Ucraina 120
FR - Francia 99
CA - Canada 98
SE - Svezia 76
JP - Giappone 73
KR - Corea 48
PL - Polonia 45
IN - India 39
NL - Olanda 36
MX - Messico 26
ID - Indonesia 24
IQ - Iraq 23
AR - Argentina 20
AT - Austria 20
ES - Italia 20
TR - Turchia 19
EC - Ecuador 17
JM - Giamaica 17
CO - Colombia 16
CR - Costa Rica 15
SV - El Salvador 14
BE - Belgio 12
HN - Honduras 12
TT - Trinidad e Tobago 12
ZA - Sudafrica 12
CL - Cile 11
LT - Lituania 11
SA - Arabia Saudita 10
EE - Estonia 9
GP - Guadalupe 9
UZ - Uzbekistan 8
MA - Marocco 7
MY - Malesia 7
GT - Guatemala 6
IR - Iran 6
PH - Filippine 6
PK - Pakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
EG - Egitto 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
PR - Porto Rico 5
TN - Tunisia 5
A1 - Anonimo 4
AU - Australia 4
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
DZ - Algeria 4
PA - Panama 4
VE - Venezuela 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
RO - Romania 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
HT - Haiti 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
PS - Palestinian Territory 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BY - Bielorussia 1
CV - Capo Verde 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
Totale 21.134
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.135
Wilmington 2.923
Houston 2.768
Ashburn 786
Singapore 727
Fairfield 526
San Jose 432
Council Bluffs 301
Ann Arbor 295
Hong Kong 288
Chandler 268
Seattle 234
Rome 192
Beijing 189
Cambridge 180
Santa Clara 171
Dublin 152
Helsinki 146
Los Angeles 125
Medford 123
New York 110
The Dalles 102
Jacksonville 96
Dearborn 84
Tokyo 67
Milan 66
Chicago 63
Monte Vista 60
North Bergen 59
Buffalo 57
Lawrence 56
Dallas 55
Lauterbourg 52
Ho Chi Minh City 51
Denver 41
Moscow 38
North Charleston 38
Hanoi 37
San Diego 36
Zhengzhou 32
Atlanta 31
Toronto 28
Brooklyn 27
Nuremberg 27
Phoenix 27
São Paulo 26
Menlo Park 25
Indianapolis 21
Kraków 21
London 21
Warsaw 21
Boardman 20
Montreal 19
Rio de Janeiro 19
Shanghai 18
Colorado Springs 17
Munich 17
Redondo Beach 17
Chennai 16
Miami 16
Naples 16
Baghdad 15
Philadelphia 15
Bologna 14
Orem 14
Seoul 14
Boston 13
Frankfurt am Main 13
Jakarta 13
San Francisco 13
Brussels 12
Columbus 12
Washington 12
Lappeenranta 11
San Salvador 11
Groningen 10
Norwalk 10
Redwood City 10
San José 10
Stockholm 10
Curitiba 9
Kingston 9
Mexico City 9
Orlando 9
Vienna 9
Charlotte 8
Cincinnati 8
Da Nang 8
Johannesburg 8
Kunming 8
Las Vegas 8
Manchester 8
Tashkent 8
Turin 8
Amsterdam 7
Bari 7
Belo Horizonte 7
Cleveland 7
Del Norte 7
Guayaquil 7
Totale 16.002
Salva come PNG Salva come JPEG
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 631
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 579
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 565
Interleukin-34 sustains inflammatory pathways in the gut 533
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 515
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 499
The dual role of Smad7 in the control of cancer growth and metastasis 490
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 490
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 490
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 483
TGF-Beta signaling manipulation as potential therapy for IBD 483
An overview of the role of innate lymphoid cells in gut infections and inflammation 483
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 480
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 479
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 476
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 475
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 473
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 473
Antisense approach to inflammatory bowel disease: Prospects and challenges 465
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 462
Defective expression of scavenger receptors in celiac disease mucosa 447
null 442
The TGF-β/Smad System in IBD Pathogenesis 432
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man 428
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 427
Targeting integrins and adhesion molecules to combat inflammatory bowel disease 403
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad 399
Smad7 positively regulates keratinocyte proliferation in psoriasis 394
Proteinase activated-receptors-associated signaling in the control of gastric cancer 378
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 345
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 290
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 282
Precision Medicine in Inflammatory Bowel Diseases 258
Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients 253
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 252
Inflammatory cytokines: from discoveries to therapies in IBD 241
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 225
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 215
Association between celiac disease and cancer 168
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 165
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 164
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 156
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 149
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 145
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 140
Novel therapeutic options for people with ulcerative colitis: an update on recent developments with Janus Kinase (JAK) inhibitors 138
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders 137
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 134
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 125
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 121
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 114
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa 109
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 108
Low frequency of COVID-19 in inflammatory bowel diseases 107
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features 98
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 96
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease 94
Metalloproteinases in inflammatory bowel diseases 94
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 93
Interleukin-34 promotes tumorigenic signals for colon cancer cells 86
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 85
Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases 84
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab 84
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease 80
Long-term outcomes and predictive factors of hospitalized patients with severe ulcerative colitis treated with intravenous corticosteroids 78
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature 78
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term 77
Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease 76
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 74
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy 74
Clinical outcome after entero-enteric anastomosis for Crohn’s disease: a case-control study 73
Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases 73
Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis. 73
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 72
Best of UEG Week 2024 68
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease 66
High Smad7 marks inflammation in patients with chronic pouchitis 61
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients 61
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 61
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data 60
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 58
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study 57
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters? 55
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease 55
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease 53
Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy 53
Vedolizumab and new‐onset spondyloarthritis: Debunking the myth 51
Quality of clinical guidelines: It matters as it impacts patient care 45
Treatment options for refractory ulcerative colitis: Small molecules, big effects 43
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitis 42
Immune cell dynamics and mechanisms of epithelial injury in celiac disease 39
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 38
CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis 36
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection 35
Reduced Taurine Serum Levels in Inflammatory Bowel Disease 35
Molecular Insights into Helicobacter pylori-Induced Gastritis and Gastric Cancer 35
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy 34
Inflammatory bowel disease: new therapies from antisense oligonucleotides 34
Advances in endoscopy in IBD diagnostics and management 33
Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis 32
Totale 21.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022528 0 0 0 29 8 45 24 18 139 64 55 146
2022/2023665 65 77 16 85 60 151 62 34 48 21 29 17
2023/2024283 33 5 13 7 20 48 23 53 5 5 17 54
2024/20252.428 34 399 332 131 52 241 132 82 195 215 364 251
2025/20264.323 311 159 386 274 350 191 565 409 445 358 625 250
2026/20272.167 379 291 765 732 0 0 0 0 0 0 0 0
Totale 21.590